Table 1 |
Validated GFR-Estimating Equations |
Table 2 |
Causes of Unusually Low or High Endogenous Creatinine Generation |
Table 3 |
Causes of Unusually Low or High Kidney Tubular Creatinine Secretion |
Table 4 |
Methods for Calculating eKt/V |
Table 4A |
Preferred Measures of the Delivered Dose (in Order of Preference) |
Table 5 |
Recommended Predialysis Blood-Drawing Procedure |
Table 6 |
Slow-Blood-Flow Method for Obtaining the Postdialysis Sample |
Table 7 |
Stop-Dialysate-Flow Method of Obtaining the Postdialysis Sample |
Table 8 |
Effect of HD Dose on Mortality |
Table 9 |
Fraction of Treatments With an spKt/V Greater Than 1.2 When Targeting 1.2 to 1.4 per Dialysis |
Table 10 |
Effect of Residual Kidney Function on Mortality |
Table 11 |
Complications That May Prompt Initiation of Kidney Replacement Therapy |
Table 12 |
Effect of High Flux Dialysis on Mortality, Cardiovascular Mortality and β2 Microglobulin (β2M) |
Table 13 |
Minimum spKt/V Values Corresponding to a stdKt/V of Approximately 2.0 per Week |
Table 14 |
Effect of Dialyzer Reuse on Mortality |
Table 15 |
Efforts to Protect RKF |
Table 16 |
Potential Insults to RKF |
Table 17 |
Effect of Pharmacologic Interventions on Loss of Residual Kidney Function |
Table 18 |
Values for k at Different Dialysis Frequencies and BUN Targets |
Table 19 |
Minimum spKt/V Required to Achieve a stdKt/V of 2.0 per Week |